LYKALABS — Lyka Labs Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Lyka Labs, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	R2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	123	81.4	188	143	93.8
Net Total Accounts Receivable
Net Total Receivables	81.3	87.4	185	202	270
Total Inventory
Total Other Current Assets
Total Current Assets	359	291	522	442	507
Net Property, Plant And Equipment	891	837	856	637	688
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	2,002	1,900	1,856	1,515	1,567
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	663	492	994	326	376
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	2,145	2,158	1,723	1,061	886
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity	-143	-258	133	454	682
Total Liabilities & Shareholders' Equity	2,002	1,900	1,856	1,515	1,567
Total Common Shares Outstanding